GAD2 and type 1 diabetes mellitus: To investigate whether the HLA-DR3-DQ2 haplotype was a determining factor in immune responses following GABA or GABA with GAD65-alum treatment in children with T1D, we performed HLA-typing on our patient samples and divided our data into their respective HLA haplotypes.